Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts?

Umberto Maggi, Tullia M. De Feo, Enzo Andorno, Umberto Cillo, Luciano De Carlis, Michele Colledan, Patrizia Burra, Nicola De Fazio, Giorgio Rossi

Research output: Contribution to journalArticle

Abstract

In situ split liver extended right grafts (SL-ERGs) are still considered marginal grafts. Our aim was to verify this statement at the present time. From 1997 to 2011, a multicenter, retrospective study based on a prospective database was performed at 9 liver transplantation (LT) centers in northern Italy; it included 382 in situ SL-ERG transplants in adults. There were 358 primary LTs and 24 retransplantations (RETXs). The 1-, 3-, and 5-year overall graft survival rate for LT with in situ SL-ERGs were 73.5%, 63.3%, and 60.7%, respectively, from 1997 to 2004 and 83.5%, 80.3%, and 80.3%, respectively, thereafter (P=0.0001). A shorter total ischemia time and fewer RETX grafts were the main differences between the characteristics of the 2 periods. From 1997 to 2011, the 1-, 3-, and 5-year graft survival rates showed a significant difference between the 358 primary LT in situ SL-ERGs and the 24 RETX in situ SL-ERGs (P60 years, RETX grafts, and urgency were the main prognostic factors for failure for all of the grafts. Although caution should be taken regarding the choice of appropriate donors, in situ SL-ERGs should no longer be considered marginal grafts for experienced LT centers. SL-ERGs should not be used in RETX settings, and when SL-ERGs are used as primary grafts, the total ischemia time should be less than 8 hours. Liver Transpl 21:500-511, 2015.

Original languageEnglish
Pages (from-to)500-511
Number of pages12
JournalLiver Transplantation
Volume21
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Multicenter Studies
Transplants
Liver
Liver Transplantation
Graft Survival
Ischemia
Italy
Retrospective Studies
Databases

ASJC Scopus subject areas

  • Surgery
  • Transplantation
  • Hepatology
  • Medicine(all)

Cite this

Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study : Are these still extended criteria liver grafts? / Maggi, Umberto; De Feo, Tullia M.; Andorno, Enzo; Cillo, Umberto; De Carlis, Luciano; Colledan, Michele; Burra, Patrizia; De Fazio, Nicola; Rossi, Giorgio.

In: Liver Transplantation, Vol. 21, No. 4, 01.04.2015, p. 500-511.

Research output: Contribution to journalArticle

Maggi, Umberto ; De Feo, Tullia M. ; Andorno, Enzo ; Cillo, Umberto ; De Carlis, Luciano ; Colledan, Michele ; Burra, Patrizia ; De Fazio, Nicola ; Rossi, Giorgio. / Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study : Are these still extended criteria liver grafts?. In: Liver Transplantation. 2015 ; Vol. 21, No. 4. pp. 500-511.
@article{981d4cfe2f0a472ebc3cbceec506eed0,
title = "Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts?",
abstract = "In situ split liver extended right grafts (SL-ERGs) are still considered marginal grafts. Our aim was to verify this statement at the present time. From 1997 to 2011, a multicenter, retrospective study based on a prospective database was performed at 9 liver transplantation (LT) centers in northern Italy; it included 382 in situ SL-ERG transplants in adults. There were 358 primary LTs and 24 retransplantations (RETXs). The 1-, 3-, and 5-year overall graft survival rate for LT with in situ SL-ERGs were 73.5{\%}, 63.3{\%}, and 60.7{\%}, respectively, from 1997 to 2004 and 83.5{\%}, 80.3{\%}, and 80.3{\%}, respectively, thereafter (P=0.0001). A shorter total ischemia time and fewer RETX grafts were the main differences between the characteristics of the 2 periods. From 1997 to 2011, the 1-, 3-, and 5-year graft survival rates showed a significant difference between the 358 primary LT in situ SL-ERGs and the 24 RETX in situ SL-ERGs (P60 years, RETX grafts, and urgency were the main prognostic factors for failure for all of the grafts. Although caution should be taken regarding the choice of appropriate donors, in situ SL-ERGs should no longer be considered marginal grafts for experienced LT centers. SL-ERGs should not be used in RETX settings, and when SL-ERGs are used as primary grafts, the total ischemia time should be less than 8 hours. Liver Transpl 21:500-511, 2015.",
author = "Umberto Maggi and {De Feo}, {Tullia M.} and Enzo Andorno and Umberto Cillo and {De Carlis}, Luciano and Michele Colledan and Patrizia Burra and {De Fazio}, Nicola and Giorgio Rossi",
year = "2015",
month = "4",
day = "1",
doi = "10.1002/lt.24070",
language = "English",
volume = "21",
pages = "500--511",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study

T2 - Are these still extended criteria liver grafts?

AU - Maggi, Umberto

AU - De Feo, Tullia M.

AU - Andorno, Enzo

AU - Cillo, Umberto

AU - De Carlis, Luciano

AU - Colledan, Michele

AU - Burra, Patrizia

AU - De Fazio, Nicola

AU - Rossi, Giorgio

PY - 2015/4/1

Y1 - 2015/4/1

N2 - In situ split liver extended right grafts (SL-ERGs) are still considered marginal grafts. Our aim was to verify this statement at the present time. From 1997 to 2011, a multicenter, retrospective study based on a prospective database was performed at 9 liver transplantation (LT) centers in northern Italy; it included 382 in situ SL-ERG transplants in adults. There were 358 primary LTs and 24 retransplantations (RETXs). The 1-, 3-, and 5-year overall graft survival rate for LT with in situ SL-ERGs were 73.5%, 63.3%, and 60.7%, respectively, from 1997 to 2004 and 83.5%, 80.3%, and 80.3%, respectively, thereafter (P=0.0001). A shorter total ischemia time and fewer RETX grafts were the main differences between the characteristics of the 2 periods. From 1997 to 2011, the 1-, 3-, and 5-year graft survival rates showed a significant difference between the 358 primary LT in situ SL-ERGs and the 24 RETX in situ SL-ERGs (P60 years, RETX grafts, and urgency were the main prognostic factors for failure for all of the grafts. Although caution should be taken regarding the choice of appropriate donors, in situ SL-ERGs should no longer be considered marginal grafts for experienced LT centers. SL-ERGs should not be used in RETX settings, and when SL-ERGs are used as primary grafts, the total ischemia time should be less than 8 hours. Liver Transpl 21:500-511, 2015.

AB - In situ split liver extended right grafts (SL-ERGs) are still considered marginal grafts. Our aim was to verify this statement at the present time. From 1997 to 2011, a multicenter, retrospective study based on a prospective database was performed at 9 liver transplantation (LT) centers in northern Italy; it included 382 in situ SL-ERG transplants in adults. There were 358 primary LTs and 24 retransplantations (RETXs). The 1-, 3-, and 5-year overall graft survival rate for LT with in situ SL-ERGs were 73.5%, 63.3%, and 60.7%, respectively, from 1997 to 2004 and 83.5%, 80.3%, and 80.3%, respectively, thereafter (P=0.0001). A shorter total ischemia time and fewer RETX grafts were the main differences between the characteristics of the 2 periods. From 1997 to 2011, the 1-, 3-, and 5-year graft survival rates showed a significant difference between the 358 primary LT in situ SL-ERGs and the 24 RETX in situ SL-ERGs (P60 years, RETX grafts, and urgency were the main prognostic factors for failure for all of the grafts. Although caution should be taken regarding the choice of appropriate donors, in situ SL-ERGs should no longer be considered marginal grafts for experienced LT centers. SL-ERGs should not be used in RETX settings, and when SL-ERGs are used as primary grafts, the total ischemia time should be less than 8 hours. Liver Transpl 21:500-511, 2015.

UR - http://www.scopus.com/inward/record.url?scp=84925845370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925845370&partnerID=8YFLogxK

U2 - 10.1002/lt.24070

DO - 10.1002/lt.24070

M3 - Article

C2 - 25545700

AN - SCOPUS:84925845370

VL - 21

SP - 500

EP - 511

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 4

ER -